Royal Bank of Canada’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-40,818
Closed -$104K 7870
2023
Q4
$104K Buy
40,818
+13,996
+52% +$32.6K ﹤0.01% 5601
2023
Q3
$64K Buy
26,822
+3,056
+13% +$6.76K ﹤0.01% 5643
2023
Q2
$54K Buy
23,766
+13,543
+132% +$38.2K ﹤0.01% 5748
2023
Q1
$26K Sell
10,223
-20,812
-67% -$59.6K ﹤0.01% 5934
2022
Q4
$77K Buy
31,035
+9,867
+47% +$27.5K ﹤0.01% 5638
2022
Q3
$61K Buy
21,168
+2,609
+14% +$11K ﹤0.01% 5636
2022
Q2
$85K Sell
18,559
-4,840
-21% -$28.8K ﹤0.01% 5454
2022
Q1
$188K Buy
23,399
+5,469
+31% +$48.2K ﹤0.01% 5150
2021
Q4
$208K Buy
17,930
+255
+1% +$3.05K ﹤0.01% 5299
2021
Q3
$219K Buy
+17,675
New +$199K ﹤0.01% 5088

Royal Bank of Canada's SLGC Position: Q1 2024 in Review

Royal Bank of Canada sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 40,818 shares — an estimated $104K sold.

Royal Bank of Canada first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $219K in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Royal Bank of Canada reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 40,818 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $104K.
  • Royal Bank of Canada first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Royal Bank of Canada's SomaLogic, Inc. Class A Common Stock position peaked at $219K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.